View ValuationAurora Labs 将来の成長Future 基準チェック /06現在、 Aurora Labsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Machinery 収益成長24.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listingお知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listingお知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2023)Full year 2024 results: AU$0.01 loss per share (improved from AU$0.014 loss in FY 2023). Net loss: AU$2.81m (loss narrowed 5.3% from FY 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.お知らせ • May 01Aurora Labs Limited, Annual General Meeting, May 30, 2024Aurora Labs Limited, Annual General Meeting, May 30, 2024, at 10:00 W. Australia Standard Time. Location: 41-43 Wittenberg Drive, Canning Vale, Western Australia Canning Vale Western Australia Australia Agenda: To consider the Ratification of Placement Shares pursuant to Listing Rule 7.1; to consider the Issue of Placement Options; to consider the Issue of Placement Shares and Placement Options to Mr Grant Mooney; and to consider other matters.お知らせ • Apr 23Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million.Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 65,166,667 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,833,333 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Transaction Features: Subsequent Direct ListingNew Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (38% average weekly change). Revenue is less than US$1m (AU$220k revenue, or US$144k). Market cap is less than US$10m (€4.92m market cap, or US$5.32m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).お知らせ • Dec 22Aurora Labs Limited ORDINARY FULLY PAID to Be Deleted from OTC EquityAurora Labs Limited ORDINARY FULLY PAID (Australia) will be deleted from OTC Equity effective December 21, 2023, due to Inactive Security.お知らせ • Nov 29Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million. Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 35,800,000 Price\Range: AUD 0.022 Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 7,000,000 Price\Range: AUD 0.022 Transaction Features: Subsequent Direct ListingNew Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€4.43m market cap, or US$4.87m).New Risk • Nov 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (46% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€3.90m market cap, or US$4.28m).お知らせ • Oct 27Aurora Labs Limited, Annual General Meeting, Nov 29, 2023Aurora Labs Limited, Annual General Meeting, Nov 29, 2023, at 09:00 W. Australia Standard Time. Location: HLB Mann Judd, Level 4, 130 Stirling Street Perth, Western Australia Western Australia Australia Agenda: To consider the Annual Report of the Company and its controlled entities for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report and the Auditor's Report; to consider remuneration report; to consider re-election of director; and to consider other matters.Reported Earnings • Aug 27Full year 2023 earnings released: EPS: AU$0.014 (vs AU$0.018 loss in FY 2022)Full year 2023 results: EPS: AU$0.014 (up from AU$0.018 loss in FY 2022). Net loss: AU$2.96m (loss narrowed 5.9% from FY 2022). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Chairman & Company Secretary Grant Mooney was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 24First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.011 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.011 loss in 1H 2022). Net loss: AU$1.69m (loss narrowed 4.9% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 26Full year 2022 earnings released: AU$0.018 loss per share (vs AU$0.031 loss in FY 2021)Full year 2022 results: AU$0.018 loss per share (up from AU$0.031 loss in FY 2021). Net loss: AU$3.15m (loss narrowed 29% from FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Apr 15Founder & CTO recently sold €211k worth of stockOn the 14th of April, David Budge sold around 3m shares on-market at roughly €0.074 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €372k.Reported Earnings • Aug 28Full year 2021 earnings released: AU$0.03 loss per share (vs AU$0.079 loss in FY 2020)Full year 2021 results: Net loss: AU$4.42m (loss narrowed 46% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Aug 03Founder & CTO recently sold €140k worth of stockOn the 29th of July, David Budge sold around 2m shares on-market at roughly €0.057 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €649k. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Aurora Labs は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:0FR - アナリストの将来予測と過去の財務データ ( )AUD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20251-4-4-3N/A9/30/20251-4-3-3N/A6/30/20251-4-3-3N/A3/31/20251-4-3-3N/A12/31/20240-4-3-2N/A9/30/20240-3-2-2N/A6/30/20240-3-2-2N/A3/31/20240-3-3-3N/A12/31/20230-3-3-3N/A9/30/20230-3-3-3N/A6/30/20230-3-3-3N/A3/31/20230-3-3-3N/A12/31/20220-3-3-3N/A9/30/20220-3-3-3N/A6/30/20220-3-3-3N/A3/31/20220-4-2-2N/A12/31/20210-4-2-2N/A9/30/20210-4-2-2N/A6/30/20210-4-2-2N/A3/31/20210-5-3-3N/A12/31/20200-5-4-4N/A9/30/20200-6-5-5N/A6/30/20200-8-7-6N/A3/31/20201-8-8-7N/A12/31/20191-8-8-8N/A9/30/20191-8N/A-8N/A6/30/20191-8N/A-8N/A3/31/20191-7N/A-7N/A12/31/20181-7N/A-6N/A9/30/20181-6N/A-6N/A6/30/20180-6N/A-6N/A3/31/20180-6N/A-5N/A12/31/20170-6N/A-5N/A9/30/20170-4N/A-4N/A6/30/20170-3N/A-4N/A3/31/20170-3N/A-3N/A12/31/20160-2N/A-2N/A9/30/20160-2N/A-2N/A6/30/2016N/A-1N/A-1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 0FRの予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 0FRの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 0FRの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 0FRの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 0FRの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 0FRの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/17 16:02終値2026/06/17 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Aurora Labs Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Board Change • May 21Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Executive Director of Strategy & Strategic Partnerships and Executive Director Andrew Garth is the most experienced director on the board, commencing their role in 2024. Independent Non- Executive Director Andrew Bottrell was the last independent director to join the board, commencing their role in 2026. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
お知らせ • Oct 14Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 5.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 59,602,251 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 46,166,980 Price\Range: AUD 0.052 Discount Per Security: AUD 0.00312 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 09Aurora Labs Limited, Annual General Meeting, Nov 17, 2025Aurora Labs Limited, Annual General Meeting, Nov 17, 2025.
New Risk • Nov 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 62% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Shareholders have been substantially diluted in the past year (62% increase in shares outstanding). Revenue is less than US$1m (AU$174k revenue, or US$112k). Minor Risk Market cap is less than US$100m (€18.3m market cap, or US$19.3m).
お知らせ • Nov 06Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 26,666,667 Price\Range: AUD 0.075 Discount Per Security: AUD 0.00375 Transaction Features: Subsequent Direct Listing
お知らせ • Sep 24Aurora Labs Limited, Annual General Meeting, Nov 14, 2024Aurora Labs Limited, Annual General Meeting, Nov 14, 2024.
Reported Earnings • Aug 23Full year 2024 earnings released: AU$0.01 loss per share (vs AU$0.014 loss in FY 2023)Full year 2024 results: AU$0.01 loss per share (improved from AU$0.014 loss in FY 2023). Net loss: AU$2.81m (loss narrowed 5.3% from FY 2023). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
お知らせ • May 01Aurora Labs Limited, Annual General Meeting, May 30, 2024Aurora Labs Limited, Annual General Meeting, May 30, 2024, at 10:00 W. Australia Standard Time. Location: 41-43 Wittenberg Drive, Canning Vale, Western Australia Canning Vale Western Australia Australia Agenda: To consider the Ratification of Placement Shares pursuant to Listing Rule 7.1; to consider the Issue of Placement Options; to consider the Issue of Placement Shares and Placement Options to Mr Grant Mooney; and to consider other matters.
お知らせ • Apr 23Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million.Aurora Labs Limited has filed a Follow-on Equity Offering in the amount of AUD 2.04 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 65,166,667 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,833,333 Price\Range: AUD 0.03 Discount Per Security: AUD 0.0018 Security Features: Attached Options Transaction Features: Subsequent Direct Listing
New Risk • Feb 25New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (38% average weekly change). Revenue is less than US$1m (AU$220k revenue, or US$144k). Market cap is less than US$10m (€4.92m market cap, or US$5.32m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
お知らせ • Dec 22Aurora Labs Limited ORDINARY FULLY PAID to Be Deleted from OTC EquityAurora Labs Limited ORDINARY FULLY PAID (Australia) will be deleted from OTC Equity effective December 21, 2023, due to Inactive Security.
お知らせ • Nov 29Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million.Aurora Labs Limited has completed a Follow-on Equity Offering in the amount of AUD 0.9416 million. Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 35,800,000 Price\Range: AUD 0.022 Security Name: Ortdinary Shares Security Type: Common Stock Securities Offered: 7,000,000 Price\Range: AUD 0.022 Transaction Features: Subsequent Direct Listing
New Risk • Nov 29New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -AU$2.6m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (47% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€4.43m market cap, or US$4.87m).
New Risk • Nov 28New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 53% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-AU$2.6m free cash flow). Share price has been highly volatile over the past 3 months (46% average weekly change). Shareholders have been substantially diluted in the past year (53% increase in shares outstanding). Revenue is less than US$1m (AU$135k revenue, or US$89k). Market cap is less than US$10m (€3.90m market cap, or US$4.28m).
お知らせ • Oct 27Aurora Labs Limited, Annual General Meeting, Nov 29, 2023Aurora Labs Limited, Annual General Meeting, Nov 29, 2023, at 09:00 W. Australia Standard Time. Location: HLB Mann Judd, Level 4, 130 Stirling Street Perth, Western Australia Western Australia Australia Agenda: To consider the Annual Report of the Company and its controlled entities for the year ended 30 June 2023, which includes the Financial Report, the Directors' Report and the Auditor's Report; to consider remuneration report; to consider re-election of director; and to consider other matters.
Reported Earnings • Aug 27Full year 2023 earnings released: EPS: AU$0.014 (vs AU$0.018 loss in FY 2022)Full year 2023 results: EPS: AU$0.014 (up from AU$0.018 loss in FY 2022). Net loss: AU$2.96m (loss narrowed 5.9% from FY 2022). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Board Change • Apr 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Chairman & Company Secretary Grant Mooney was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 24First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.011 loss in 1H 2022)First half 2023 results: AU$0.009 loss per share (improved from AU$0.011 loss in 1H 2022). Net loss: AU$1.69m (loss narrowed 4.9% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 26Full year 2022 earnings released: AU$0.018 loss per share (vs AU$0.031 loss in FY 2021)Full year 2022 results: AU$0.018 loss per share (up from AU$0.031 loss in FY 2021). Net loss: AU$3.15m (loss narrowed 29% from FY 2021). Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has fallen by 50% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Apr 15Founder & CTO recently sold €211k worth of stockOn the 14th of April, David Budge sold around 3m shares on-market at roughly €0.074 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €372k.
Reported Earnings • Aug 28Full year 2021 earnings released: AU$0.03 loss per share (vs AU$0.079 loss in FY 2020)Full year 2021 results: Net loss: AU$4.42m (loss narrowed 46% from FY 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 34% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Aug 03Founder & CTO recently sold €140k worth of stockOn the 29th of July, David Budge sold around 2m shares on-market at roughly €0.057 per share. This was the largest sale by an insider in the last 3 months. David has been a seller over the last 12 months, reducing personal holdings by €649k.